Print

Endo Health Solutions Inc. (ENDP) Unloads Urology Unit in Hopes of Becoming Profitable Again  
8/13/2013 7:54:34 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Endo Health Solutions (Nasdaq: ENDP [FREE Stock Trend Analysis]) today announced that its wholly owned subsidiary, HealthTronics, Inc. has entered into a definitive agreement to sell its anatomical pathology business, HealthTronics Laboratory Solutions, Inc., ("HLS") to Metamark Genetics, Inc. ("Metamark") for an undisclosed amount. As previously announced Endo Health Solutions is pursuing strategic alternatives for HealthTronics, Inc. and believes the sale of HLS creates progress in this process.

Help employers find you! Check out all the jobs and post your resume.

//-->